Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucralfate suspension gel for artificial ulcer healing after gastric ESD
ChiCTR2100053078Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sucralfate, rebamipide and esomeprazole in gastric cancer (GC) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Ulcer area reduction rate. Started Dec 2021; status: recruiting.
02
Drugs
sucralfaterebamipideesomeprazole
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2100053078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053078.